Upper Respiratory Tract Infection Clinical Trial
Official title:
Phase 3 Study of Montelukast as Prophylaxis for Upper Respiratory Tract Infections in Children
Viral upper respiratory tract infection (URI) is one of the most common diseases among
toddlers and pre-school children.Complete and effective prevention measures for URI are
currently unavailable.
Montelukast (Singulair ) is a selective leukotriene-receptor antagonist that inhibits the
cysteinyl leukotriene 1 receptor. It is well tolerated and safe even in young children.
Montelukast is an effective treatment for asthma (and allergic rhinitis from 1 year of age.
Infections with viruses causing URI such as Influenza A, Rhinovirus and respiratory
syncitial virus increases leukotriens levels in nasal secretions. Therefore, one may
postulate that leukotriens inhibitors may reduce symptoms during URI. However the effect of
montelukast as a treatment for non-specific cough was not properly studied and there are no
studies on the effect of montelukast as prevention for URI.
Hypothesis: Prophylactic treatment with Montelukast will reduce the incidence and severity
of upper respiratory infection in children.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06052540 -
Probiotic Supplementation in Children Affected by Upper Respiratory Infections
|
N/A | |
| Completed |
NCT04960878 -
The Effect of Synbiotics on the Upper Respiratory Tract Infection
|
N/A | |
| Terminated |
NCT00979667 -
A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection
|
Phase 3 | |
| Recruiting |
NCT04479657 -
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
|
Early Phase 1 | |
| Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
| Recruiting |
NCT06065176 -
The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection
|
Phase 4 | |
| Recruiting |
NCT01985620 -
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
|
N/A | |
| Completed |
NCT01875757 -
Effect of Supplementation With Vitamin D on the Acute Bronchitis Prevention During the First Year of Life
|
Phase 3 | |
| Completed |
NCT00393835 -
A Trial Of Azithromycin SR For The Treatment Of Laryngopharyngitis or Tonsillitis or Acute Bacterial Rhinosinusitis
|
Phase 3 | |
| Completed |
NCT06149117 -
Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China
|
Phase 4 | |
| Not yet recruiting |
NCT05612893 -
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
|
||
| Active, not recruiting |
NCT05569330 -
Effect of Aerosol Filtering on Infectious Diseases in Day Care
|
N/A | |
| Recruiting |
NCT05374070 -
Antiviral Activity of Oral Probiotics
|
N/A | |
| Completed |
NCT00707941 -
Oseltamivir Randomised Controlled Efficacy Trial
|
Phase 3 | |
| Completed |
NCT00858494 -
Homeopathic Cold Medicine for Children
|
N/A | |
| Completed |
NCT04955327 -
To Compare the Efficacy and Tolerability of A. Paniculata/A. Chilensis in Individuals With URTI
|
Phase 3 | |
| Completed |
NCT01735084 -
Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life
|
Phase 4 | |
| Not yet recruiting |
NCT03461692 -
A Registry Study of 100 Thousand Cases of Pediatric Patients on Reduning Injection（a Chinese Medicine Injection）Used in Hospitals in China
|
N/A | |
| Completed |
NCT03011515 -
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
|
||
| Recruiting |
NCT05915390 -
Walnut and Immunity Study
|
N/A |